ALTAO — Aton SA Share News
0.000.00%
Last trade - 00:00- €9.44m
- €14.28m
- €0.66m
Brief: Hybrigenics FY Operating Loss Narrows To 1.4 Million Euros
Brief: DMS Group Finalises Clinical Trial Study For Osteoarthritis Treatment
Brief: Hybrigenics H1 Net Loss Narrows To 0.4 Million Euros
Brief: Hybrigenics: DMS Receives Waiver By French Regulator (AMF) To Take Over Hybrigenics
Brief: Hybrigenics FY Revenue Down At 0.1 Million Euros
Brief: DMS Group In Exclusive Negotiations For Controlling Stake Hybrigenics
Brief: Hybrigenics Receives Takeover Bid
Brief: Moonstone Investments Withdraws Unsolicited Bid For Hybrigenics
Brief: Hybrigenics Asks Moonstone Investments To Clarify Its Offer
Brief: Hybrigenics End Of October Cash Position Of 3.1 Million Euros
Brief: Hybrigenics Requests Trading Suspension
Brief: Hybrigenics Says End Of Recruitment Of Phase II Clinical Study Of Inecalcitol In Acute Myeloid Leukemia
Brief: Hybrigenics FY Operating Loss Widens To 7.4 Million Euros, Presents Update On Inecalcitol Clinical Studies
Brief: Hybrigenics: Broad-Spectrum Inhibitor Of Ubiquitin-Specific Proteases Shows Antiviral Activity Against Human Adenoviruses
Brief: Hybrigenics Announces Sale Of Helixio
Brief: Hybrigenics H1 operating loss widens to 3.5 million euros
Brief: Hybrigenics' compound inhibits USP10 and shows activity in preclinical models of AML
Brief: Hybrigenics raises 6.8 million euros in capital increase
Brief: Hybrigenics FY operating loss of 4.3 million euros